These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 38320955)
1. Validating methods used to identify non-adherence adverse drug events in Canadian administrative health data. Wickham ME; McGrail KM; Law MR; Cragg A; Hohl CM Br J Clin Pharmacol; 2024 May; 90(5):1240-1246. PubMed ID: 38320955 [TBL] [Abstract][Full Text] [Related]
2. Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events. Wickham ME; McGrail KM; Law MR; Cragg A; Hohl CM Br J Clin Pharmacol; 2024 Jul; 90(7):1688-1698. PubMed ID: 38604986 [TBL] [Abstract][Full Text] [Related]
3. Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Wickham ME; McGrail KM; Law MR; Cragg A; Hohl CM Pharmacoepidemiol Drug Saf; 2024 Sep; 33(9):e70012. PubMed ID: 39300754 [TBL] [Abstract][Full Text] [Related]
5. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Buysman EK; Liu F; Hammer M; Langer J Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470 [TBL] [Abstract][Full Text] [Related]
6. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication. Campagna EJ; Muser E; Parks J; Morrato EH J Manag Care Spec Pharm; 2014 Jul; 20(7):756-66. PubMed ID: 24967528 [TBL] [Abstract][Full Text] [Related]
7. Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis. Gor D; Lee TA; Schumock GT; Walton SM; Gerber BS; Nutescu EA; Touchette DR J Manag Care Spec Pharm; 2020 Jan; 26(1):67-75. PubMed ID: 31880221 [TBL] [Abstract][Full Text] [Related]
8. Determining the optimal threshold for medication adherence in adult asthma patients: an analysis of British Columbia administrative health database in Canada. Asamoah-Boaheng M; Farrell J; Osei Bonsu K; Midodzi WK J Asthma; 2022 Dec; 59(12):2449-2460. PubMed ID: 34871127 [TBL] [Abstract][Full Text] [Related]
9. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Dashputre AA; Gatwood KS; Gatwood J J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965 [TBL] [Abstract][Full Text] [Related]
10. Comparing adherence and persistence across 6 chronic medication classes. Yeaw J; Benner JS; Walt JG; Sian S; Smith DB J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264 [TBL] [Abstract][Full Text] [Related]
11. Real-World Health Plan Data Analysis: Key Trends in Medication Adherence and Overall Costs in Patients with HIV. Kangethe A; Polson M; Lord TC; Evangelatos T; Oglesby A J Manag Care Spec Pharm; 2019 Jan; 25(1):88-93. PubMed ID: 30589631 [TBL] [Abstract][Full Text] [Related]
12. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization. Sun P; Lian J Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064 [TBL] [Abstract][Full Text] [Related]
13. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis. Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917 [TBL] [Abstract][Full Text] [Related]
14. Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy - An Observational Pharmacy Claims Database Study. Umeda T; Hayashi A; Fujimoto G; Piao Y; Matsui N; Tokita S Circ J; 2019 Jul; 83(8):1689-1697. PubMed ID: 31281135 [TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder. Broder MS; Greene M; Chang E; Hartry A; Yan T; Yermilov I J Med Econ; 2019 Jan; 22(1):63-70. PubMed ID: 30376745 [TBL] [Abstract][Full Text] [Related]
16. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Sattler EL; Lee JS; Perri M Drugs Aging; 2013 Jun; 30(6):383-99. PubMed ID: 23553512 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a drug adherence index for COPD. Bengtson LGS; Bancroft T; Schilling C; Buikema AR; Stanford RH J Manag Care Spec Pharm; 2021 Feb; 27(2):198-209. PubMed ID: 33506734 [No Abstract] [Full Text] [Related]
18. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes. Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968 [TBL] [Abstract][Full Text] [Related]
19. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients. Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848 [TBL] [Abstract][Full Text] [Related]
20. Impact of hospitalization on medication adherence estimation in claims data. Dong YH; Choudhry NK; Krumme A; Lee MP; Wu LC; Lai MS; Gagne JJ J Clin Pharm Ther; 2017 Jun; 42(3):318-328. PubMed ID: 28370404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]